Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial
Luke Tzu-Chi Liu, Cheng-Hsun Chiu, Nan-Chang Chiu, Boon-Fatt Tan, Chien-Yu Lin, Hao-Yuan Cheng, Meei-Yun Lin, View ORCID ProfileChia-En Lien, Charles Chen, Li-Min Huang
doi: https://doi.org/10.1101/2022.03.14.22272325
Luke Tzu-Chi Liu
1Medigen Vaccine Biologics Corporation, Taipei, Taiwan
Cheng-Hsun Chiu
2Department of Pediatrics, Chang Gung Children’s Hospital, Chang Gung University College of Medicine, Taoyuan City, Taiwan
Nan-Chang Chiu
3Department of Pediatrics, MacKay Children’s Hospital, Taipei City, Taiwan
Boon-Fatt Tan
4Department of Pediatrics, National Taiwan University Hospital Hsinchu Branch, Hsinchu County, Taiwan
Chien-Yu Lin
5Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu City, Taiwan
Hao-Yuan Cheng
1Medigen Vaccine Biologics Corporation, Taipei, Taiwan
Meei-Yun Lin
1Medigen Vaccine Biologics Corporation, Taipei, Taiwan
Chia-En Lien
1Medigen Vaccine Biologics Corporation, Taipei, Taiwan
6Institute of Public Health, National Yang-Ming Chiao Tung University, Taipei City, Taiwan
Charles Chen
1Medigen Vaccine Biologics Corporation, Taipei, Taiwan
Li-Min Huang
7Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan

Data Availability
All data produced in the present work are contained in the manuscript
Posted March 15, 2022.
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial
Luke Tzu-Chi Liu, Cheng-Hsun Chiu, Nan-Chang Chiu, Boon-Fatt Tan, Chien-Yu Lin, Hao-Yuan Cheng, Meei-Yun Lin, Chia-En Lien, Charles Chen, Li-Min Huang
medRxiv 2022.03.14.22272325; doi: https://doi.org/10.1101/2022.03.14.22272325
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial
Luke Tzu-Chi Liu, Cheng-Hsun Chiu, Nan-Chang Chiu, Boon-Fatt Tan, Chien-Yu Lin, Hao-Yuan Cheng, Meei-Yun Lin, Chia-En Lien, Charles Chen, Li-Min Huang
medRxiv 2022.03.14.22272325; doi: https://doi.org/10.1101/2022.03.14.22272325
Subject Area
Subject Areas
- Addiction Medicine (242)
- Allergy and Immunology (523)
- Anesthesia (125)
- Cardiovascular Medicine (1426)
- Dermatology (158)
- Emergency Medicine (292)
- Epidemiology (10308)
- Gastroenterology (529)
- Genetic and Genomic Medicine (2637)
- Geriatric Medicine (254)
- Health Economics (497)
- Health Informatics (1740)
- Health Policy (790)
- Hematology (268)
- HIV/AIDS (568)
- Medical Education (273)
- Medical Ethics (83)
- Nephrology (291)
- Neurology (2466)
- Nursing (145)
- Nutrition (379)
- Oncology (1327)
- Ophthalmology (403)
- Orthopedics (147)
- Otolaryngology (238)
- Pain Medicine (171)
- Palliative Medicine (51)
- Pathology (343)
- Pediatrics (784)
- Primary Care Research (296)
- Public and Global Health (5019)
- Radiology and Imaging (895)
- Respiratory Medicine (682)
- Rheumatology (309)
- Sports Medicine (246)
- Surgery (299)
- Toxicology (45)
- Transplantation (141)
- Urology (108)